Stent vs. Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction 2 - STOP-AMI 2

Description:

The STOP-AMI 2 trial was a randomized trial designed to compare coronary stenting to fibrinolytic therapy with alteplase, both combined with abciximab, in patients with ST-elevation myocardial infarction (STEMI).